These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 39105380)

  • 1. Tyrosinase Inhibition and Antimelanogenic Effects of Resorcinol-Containing Compounds.
    Beaumet M; Lazinski LM; Maresca M; Haudecoeur R
    ChemMedChem; 2024 Aug; ():e202400314. PubMed ID: 39105380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural dynamics and susceptibility of isobutylamido thiazolyl resorcinol (Thiamidol
    Mahalapbutr P; Nuramrum N; Rungrotmongkol T; Kongtaworn N; Sabuakham S
    J Biomol Struct Dyn; 2023; 41(21):11810-11817. PubMed ID: 36644799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urolithin and Reduced Urolithin Derivatives as Potent Inhibitors of Tyrosinase and Melanogenesis: Importance of the 4-Substituted Resorcinol Moiety.
    Lee S; Choi H; Park Y; Jung HJ; Ullah S; Choi I; Kang D; Park C; Ryu IY; Jeong Y; Hwang Y; Hong S; Chun P; Moon HR
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catechol-mimicking transition-state analogues as non-oxidizable inhibitors of tyrosinases.
    Beaumet M; Lazinski LM; Maresca M; Haudecoeur R
    Eur J Med Chem; 2023 Nov; 259():115672. PubMed ID: 37487307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resorcinol-based hemiindigoid derivatives as human tyrosinase inhibitors and melanogenesis suppressors in human melanoma cells.
    Roulier B; Rush I; Lazinski LM; Pérès B; Olleik H; Royal G; Fishman A; Maresca M; Haudecoeur R
    Eur J Med Chem; 2023 Jan; 246():114972. PubMed ID: 36462443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azole inhibitors of mushroom and human tyrosinases: Current advances and prospects of drug development for melanogenic dermatological disorders.
    Ghani U
    Eur J Med Chem; 2022 Sep; 239():114525. PubMed ID: 35717871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p-coumaric acid not only inhibits human tyrosinase activity in vitro but also melanogenesis in cells exposed to UVB.
    An SM; Koh JS; Boo YC
    Phytother Res; 2010 Aug; 24(8):1175-80. PubMed ID: 20077437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of 4-amino-2',4'-dihydroxyindanone derivatives as potent inhibitors of tyrosinase and melanin biosynthesis in human melanoma cells.
    Lazinski LM; Beaumet M; Roulier B; Gay R; Royal G; Maresca M; Haudecoeur R
    Eur J Med Chem; 2024 Feb; 266():116165. PubMed ID: 38262119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(3,5-dihydroxybenzoyl)-6-hydroxytryptamine as a novel human tyrosinase inhibitor that inactivates the enzyme in cooperation with l-3,4-dihydroxyphenylalanine.
    Yamazaki Y; Kawano Y
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1536-40. PubMed ID: 21048351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase.
    Mann T; Gerwat W; Batzer J; Eggers K; Scherner C; Wenck H; Stäb F; Hearing VJ; Röhm KH; Kolbe L
    J Invest Dermatol; 2018 Jul; 138(7):1601-1608. PubMed ID: 29427586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 3-hydroxyquinolin-2(1H)-one derivatives as inhibitors of tyrosinase.
    Jacobs ME; Petzer JP; Pretorius J; Cloete SJ; Crous C; Petzer A
    Bioorg Med Chem Lett; 2024 Sep; 109():129823. PubMed ID: 38823727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic studies of the inactivation of tyrosinase by resorcinol.
    Stratford MR; Ramsden CA; Riley PA
    Bioorg Med Chem; 2013 Mar; 21(5):1166-73. PubMed ID: 23352755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural and synthetic flavonoid derivatives as new potential tyrosinase inhibitors: a systematic review.
    Obaid RJ; Mughal EU; Naeem N; Sadiq A; Alsantali RI; Jassas RS; Moussa Z; Ahmed SA
    RSC Adv; 2021 Jun; 11(36):22159-22198. PubMed ID: 35480807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanogenesis inhibition by tetrahydropterines.
    García-Molina F; Munoz-Munoz JL; Acosta JR; García-Ruiz PA; Tudela J; García-Cánovas F; Rodríguez-López JN
    Biochim Biophys Acta; 2009 Dec; 1794(12):1766-74. PubMed ID: 19695351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic Effect of DIBOA and Verbascoside from
    Matos P; Paranhos A; Batista MT; Figueirinha A
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways.
    Fernandez-Julia PJ; Tudela-Serrano J; Garcia-Molina F; Garcia-Canovas F; Garcia-Jimenez A; Munoz-Munoz JL
    Biotechnol Appl Biochem; 2021 Aug; 68(4):823-831. PubMed ID: 32776353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Based Design, Synthesis, Biological Evaluation and Molecular Docking Study of 4-Hydroxy-N'-methylenebenzohydrazide Derivatives Acting as Tyrosinase Inhibitors with Potentiate Anti-Melanogenesis Activities.
    Iraji A; Khoshneviszadeh M; Bakhshizadeh P; Edraki N; Khoshneviszadeh M
    Med Chem; 2020; 16(7):892-902. PubMed ID: 31339074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of 3,4-dihydroxy-L-phenylalanine using novel tyrosinases from Bacillus megaterium.
    Cha GS; Mok JA; Yun CH; Park CM
    Enzyme Microb Technol; 2022 Oct; 160():110069. PubMed ID: 35696779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial.
    Lima PB; Dias JAF; Cassiano DP; Esposito ACC; Miot LDB; Bagatin E; Miot HA
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1881-1887. PubMed ID: 33988887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Resorcinol-Based Polycyclic Structures as Tyrosinase Inhibitors for Treatment of Parkinson's Disease.
    Li Q; Mo J; Xiong B; Liao Q; Chen Y; Wang Y; Xing S; He S; Lyu W; Zhang N; Sun H
    ACS Chem Neurosci; 2022 Jan; 13(1):81-96. PubMed ID: 34882402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.